1. Home
  2. WAVE vs BMEA Comparison

WAVE vs BMEA Comparison

Compare WAVE & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

N/A

Current Price

$3.54

Market Cap

47.5M

Sector

Utilities

ML Signal

N/A

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

N/A

Current Price

$0.59

Market Cap

42.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WAVE
BMEA
Founded
2011
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.5M
42.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
WAVE
BMEA
Price
$3.54
$0.59
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
★ $14.75
$6.17
AVG Volume (30 Days)
9.8K
★ 1.0M
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 69.19
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.65
$0.45
52 Week High
$10.87
$2.24

Technical Indicators

Market Signals
Indicator
WAVE
BMEA
Relative Strength Index (RSI) 30.23 39.17
Support Level N/A $0.55
Resistance Level $4.92 $0.69
Average True Range (ATR) 0.38 0.07
MACD -0.04 0.02
Stochastic Oscillator 7.30 55.37

Price Performance

Historical Comparison
WAVE
BMEA

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient wave energy conversion, or WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographically, it has a presence in Israel, the USA, and Mexico.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

Share on Social Networks: